4/22
08:09 am
tara
Protara Therapeutics, Inc. (NASDAQ: TARA) had its price target raised by analysts at Oppenheimer Holdings Inc. from $26.00 to $30.00. They now have an "outperform" rating on the stock.
Medium
Report
Protara Therapeutics, Inc. (NASDAQ: TARA) had its price target raised by analysts at Oppenheimer Holdings Inc. from $26.00 to $30.00. They now have an "outperform" rating on the stock.
4/12
12:07 pm
tara
Here's Why Protara Therapeutics (TARA) Is a Great 'Buy the Bottom' Stock Now [Yahoo! Finance]
Low
Report
Here's Why Protara Therapeutics (TARA) Is a Great 'Buy the Bottom' Stock Now [Yahoo! Finance]
4/8
08:10 am
tara
Protara Therapeutics, Inc. (NASDAQ: TARA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
Medium
Report
Protara Therapeutics, Inc. (NASDAQ: TARA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
4/5
03:13 pm
tara
Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity [Yahoo! Finance]
Medium
Report
Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity [Yahoo! Finance]
4/5
08:08 am
tara
Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing [Yahoo! Finance]
High
Report
Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing [Yahoo! Finance]
4/5
08:08 am
tara
Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC [Yahoo! Finance]
High
Report
Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC [Yahoo! Finance]
4/5
08:05 am
tara
Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition [Yahoo! Finance]
High
Report
Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition [Yahoo! Finance]
4/5
08:04 am
tara
Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing
High
Report
Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing
4/5
08:02 am
tara
Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition
High
Report
Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition
4/5
08:00 am
tara
Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC
Medium
Report
Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC
3/18
03:10 pm
tara
Protara Therapeutics, Inc. (NASDAQ: TARA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
Low
Report
Protara Therapeutics, Inc. (NASDAQ: TARA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
3/13
08:00 am
tara
Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Low
Report
Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2/28
08:14 am
tara
Protara Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference [Yahoo! Finance]
Medium
Report
Protara Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference [Yahoo! Finance]
2/28
08:00 am
tara
Protara Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
Medium
Report
Protara Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
2/22
09:36 am
tara
Protara: A Bombed Out Biotech With A Very Positive Skew [Seeking Alpha]
Low
Report
Protara: A Bombed Out Biotech With A Very Positive Skew [Seeking Alpha]
2/17
07:36 am
tara
We're Keeping An Eye On Protara Therapeutics' (NASDAQ:TARA) Cash Burn Rate [Yahoo! Finance]
Low
Report
We're Keeping An Eye On Protara Therapeutics' (NASDAQ:TARA) Cash Burn Rate [Yahoo! Finance]
1/31
07:30 am
tara
Protara Therapeutics to Participate in Upcoming Investor Conferences
Medium
Report
Protara Therapeutics to Participate in Upcoming Investor Conferences